Literature DB >> 32295925

Ca2+ Ions Promote Fusion of Middle East Respiratory Syndrome Coronavirus with Host Cells and Increase Infectivity.

Marco R Straus1, Tiffany Tang2, Alex L Lai3, Annkatrin Flegel1,4, Miya Bidon2, Jack H Freed3, Susan Daniel5, Gary R Whittaker6.   

Abstract

Fusion with, and subsequent entry into, the host cell is one of the critical steps in the life cycle of enveloped viruses. For Middle East respiratory syndrome coronavirus (MERS-CoV), the spike (S) protein is the main determinant of viral entry. Proteolytic cleavage of the S protein exposes its fusion peptide (FP), which initiates the process of membrane fusion. Previous studies on the related severe acute respiratory syndrome coronavirus (SARS-CoV) FP have shown that calcium ions (Ca2+) play an important role in fusogenic activity via a Ca2+ binding pocket with conserved glutamic acid (E) and aspartic acid (D) residues. SARS-CoV and MERS-CoV FPs share a high sequence homology, and here, we investigated whether Ca2+ is required for MERS-CoV fusion by screening a mutant array in which E and D residues in the MERS-CoV FP were substituted with neutrally charged alanines (A). Upon verifying mutant cell surface expression and proteolytic cleavage, we tested their ability to mediate pseudoparticle (PP) infection of host cells in modulating Ca2+ environments. Our results demonstrate that intracellular Ca2+ enhances MERS-CoV wild-type (WT) PP infection by approximately 2-fold and that E891 is a crucial residue for Ca2+ interaction. Subsequent electron spin resonance (ESR) experiments revealed that this enhancement could be attributed to Ca2+ increasing MERS-CoV FP fusion-relevant membrane ordering. Intriguingly, isothermal calorimetry showed an approximate 1:1 MERS-CoV FP to Ca2+ ratio, as opposed to an 1:2 SARS-CoV FP to Ca2+ ratio, suggesting significant differences in FP Ca2+ interactions of MERS-CoV and SARS-CoV FP despite their high sequence similarity.IMPORTANCE Middle East respiratory syndrome coronavirus (MERS-CoV) is a major emerging infectious disease with zoonotic potential and has reservoirs in dromedary camels and bats. Since its first outbreak in 2012, the virus has repeatedly transmitted from camels to humans, with 2,468 confirmed cases causing 851 deaths. To date, there are no efficacious drugs and vaccines against MERS-CoV, increasing its potential to cause a public health emergency. In order to develop novel drugs and vaccines, it is important to understand the molecular mechanisms that enable the virus to infect host cells. Our data have found that calcium is an important regulator of viral fusion by interacting with negatively charged residues in the MERS-CoV FP region. This information can guide therapeutic solutions to block this calcium interaction and also repurpose already approved drugs for this use for a fast response to MERS-CoV outbreaks.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  MERS; coronavirus; fusion; fusion peptide; membrane fusion; spike protein; viral fusion

Mesh:

Substances:

Year:  2020        PMID: 32295925      PMCID: PMC7307142          DOI: 10.1128/JVI.00426-20

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  The Interaction between Influenza HA Fusion Peptide and Transmembrane Domain Affects Membrane Structure.

Authors:  Alex L Lai; Jack H Freed
Journal:  Biophys J       Date:  2015-12-15       Impact factor: 4.033

2.  Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2.

Authors:  Kazuya Shirato; Miyuki Kawase; Shutoku Matsuyama
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

3.  HIV gp41 fusion peptide increases membrane ordering in a cholesterol-dependent fashion.

Authors:  Alex L Lai; Jack H Freed
Journal:  Biophys J       Date:  2014-01-07       Impact factor: 4.033

4.  Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia.

Authors:  Ali M Zaki; Sander van Boheemen; Theo M Bestebroer; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  N Engl J Med       Date:  2012-10-17       Impact factor: 91.245

5.  The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex.

Authors:  Berend Jan Bosch; Ruurd van der Zee; Cornelis A M de Haan; Peter J M Rottier
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

6.  Characterization of a highly conserved domain within the severe acute respiratory syndrome coronavirus spike protein S2 domain with characteristics of a viral fusion peptide.

Authors:  Ikenna G Madu; Shoshannah L Roth; Sandrine Belouzard; Gary R Whittaker
Journal:  J Virol       Date:  2009-05-13       Impact factor: 5.103

7.  Evidence for camel-to-human transmission of MERS coronavirus.

Authors:  Esam I Azhar; Sherif A El-Kafrawy; Suha A Farraj; Ahmed M Hassan; Muneera S Al-Saeed; Anwar M Hashem; Tariq A Madani
Journal:  N Engl J Med       Date:  2014-06-04       Impact factor: 91.245

8.  Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes.

Authors:  Birke Bartosch; Jean Dubuisson; François-Loïc Cosset
Journal:  J Exp Med       Date:  2003-03-03       Impact factor: 14.307

Review 9.  Middle East respiratory syndrome: what we learned from the 2015 outbreak in the Republic of Korea.

Authors:  Myoung-Don Oh; Wan Beom Park; Sang-Won Park; Pyoeng Gyun Choe; Ji Hwan Bang; Kyoung-Ho Song; Eu Suk Kim; Hong Bin Kim; Nam Joong Kim
Journal:  Korean J Intern Med       Date:  2018-02-27       Impact factor: 2.884

10.  Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC.

Authors:  V Stalin Raj; Huihui Mou; Saskia L Smits; Dick H W Dekkers; Marcel A Müller; Ronald Dijkman; Doreen Muth; Jeroen A A Demmers; Ali Zaki; Ron A M Fouchier; Volker Thiel; Christian Drosten; Peter J M Rottier; Albert D M E Osterhaus; Berend Jan Bosch; Bart L Haagmans
Journal:  Nature       Date:  2013-03-14       Impact factor: 49.962

View more
  30 in total

Review 1.  Ion channel inhibition against COVID-19: A novel target for clinical investigation.

Authors:  Eliano P Navarese; Rita L Musci; Lara Frediani; Paul A Gurbel; Jacek Kubica
Journal:  Cardiol J       Date:  2020-07-09       Impact factor: 2.737

2.  Broad-spectrum Respiratory Virus Entry Inhibitors.

Authors:  Hanjun Zhao; Kwok-Yung Yuen
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

3.  Using Shapes of COVID-19 Positive Patient-Specific Trajectories for Mortality Prediction.

Authors:  Alaleh Azhir; Soheila Talebi; Louis-Henri Merino; Thomas Lukasiewicz; Edgar Argulian; Jagat Narula; Borislava Mihaylova
Journal:  AMIA Annu Symp Proc       Date:  2022-05-23

4.  Could dantrolene be explored as a repurposed drug to treat COVID-19 patients by restoring intracellular calcium homeostasis?

Authors:  B Jiang; S Liang; G Liang; H Wei
Journal:  Eur Rev Med Pharmacol Sci       Date:  2020-10       Impact factor: 3.507

Review 5.  Coronavirus membrane fusion mechanism offers a potential target for antiviral development.

Authors:  Tiffany Tang; Miya Bidon; Javier A Jaimes; Gary R Whittaker; Susan Daniel
Journal:  Antiviral Res       Date:  2020-04-06       Impact factor: 5.970

6.  Membranotropic and biological activities of the membrane fusion peptides from SARS-CoV spike glycoprotein: The importance of the complete internal fusion peptide domain.

Authors:  Luis Guilherme Mansor Basso; Ana Eliza Zeraik; Ana Paula Felizatti; Antonio José Costa-Filho
Journal:  Biochim Biophys Acta Biomembr       Date:  2021-07-15       Impact factor: 3.747

7.  Traditional Chinese Medicine and Western Medicine Share Similar Philosophical Approaches to Fight COVID-19.

Authors:  Fangfang Zhao; Zhenhong Yang; Ningqun Wang; Kunlin Jin; Yumin Luo
Journal:  Aging Dis       Date:  2021-08-01       Impact factor: 6.745

Review 8.  Endocrine and metabolic aspects of the COVID-19 pandemic.

Authors:  Mónica Marazuela; Andrea Giustina; Manuel Puig-Domingo
Journal:  Rev Endocr Metab Disord       Date:  2020-12       Impact factor: 6.514

Review 9.  Various Facets of Pathogenic Lipids in Infectious Diseases: Exploring Virulent Lipid-Host Interactome and Their Druggability.

Authors:  Ruchika Dadhich; Shobhna Kapoor
Journal:  J Membr Biol       Date:  2020-08-24       Impact factor: 1.843

10.  Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19.

Authors:  Luigi Di Filippo; Anna Maria Formenti; Patrizia Rovere-Querini; Michele Carlucci; Caterina Conte; Fabio Ciceri; Alberto Zangrillo; Andrea Giustina
Journal:  Endocrine       Date:  2020-06-12       Impact factor: 3.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.